Strategy of Continued Versus Interrupted Novel Oral Anti-coagulant at Time of Device Surgery in Patients With Moderate to High Risk of Arterial Thromboembolic Events

NCT01675076 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
663
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Ottawa Heart Institute Research Corporation

Collaborators